Health
Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved – Monthly Prescribing Reference
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
The Food and Drug Administration (FDA) has approved a multidose vial presentation of Audenz (influenza A
Continue Reading
-
General17 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News20 hours agoSanta drops in for carols
-
General23 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Business23 hours agoThe best Australian stock you’ve never heard of